SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in conversation as the community highlights its 15-year history as a parody of Bitcoin, with supporters framing it as a cultural staple that is finally gaining on-chain traction on Solana. Investors are actively debating its potential to flip market perceptions while emphasizing its unique lore and the recent involvement of verified project channels.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is currently navigating a period of heightened volatility as the market balances institutional ETF inflows against ongoing geopolitical tensions surrounding the Strait of Hormuz. Investors remain focused on critical price support levels while monitoring whether ongoing diplomatic negotiations will resolve regional conflicts or lead to further market instability.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors closely monitor the upcoming U.S. Supreme Court decision on a patent dispute involving 'skinny label' generic competition, a critical legal catalyst that could dictate future U.S. market exclusivity. The community is focused on recent preliminary financial highlights, including positive cash flow and an improved balance sheet, while weighing these fundamentals against ongoing litigation risks and potential M&A prospects at the J.P. Morgan Healthcare Conference.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility as investors debate the impact of Google's 'Stitch' AI design tool on its competitive moat and long-term growth prospects. While some in the community see the current price pullback as an attractive entry point for a platform with strong enterprise retention, others remain cautious due to ongoing insider selling and broader software sector repricing.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz due to its ultra-low circulating supply and potential for volatility, which traders believe could lead to rapid price appreciation if trading volume increases. Community sentiment is deeply divided, with many proponents highlighting upcoming DeFi and DePin integrations as major catalysts, while others express frustration over the asset's historical price decline and lack of sustained momentum.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is trending as investors react to its latest earnings report and a strategic shift toward private market research, while community discussions focus on its growing influence in AI infrastructure and potential impacts of its recent bitcoin ETF filing.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is experiencing intense volatility and community speculation as traders bet on a potential short squeeze driven by its ultra-low float and active SPAC merger news. The conversation is currently dominated by high-risk retail sentiment, with many participants comparing it to other recent rapid runners and debating whether the stock will see an explosive move or a continued correction.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is capturing significant attention as the native token of the Hyperliquid decentralized exchange, with community members highlighting its massive trading volume and dominance in the perpetual futures market. Investors are particularly focused on the token's deflationary mechanisms and its growing role as a central hub for decentralized finance, with many noting its performance relative to traditional assets and other altcoins.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy Corp

Constellation Energy is currently trending as investors weigh the impact of new federal loan support for nuclear infrastructure against recent regulatory uncertainty surrounding power grid pricing and earnings guidance. The community is actively debating the stock's position as a critical baseload energy provider for AI hyperscalers, with ongoing discussion over whether recent market volatility presents a buying opportunity or a signal of cooling sentiment toward the nuclear power trade.

Bux the rabbit is a memecoin with the main goal to provide an honest, transparent and fun memecoin to the cryptocurrency space. We launched with 80% in the liquidity pool, and the remaining tokens vested to provide a fair chance to all investors. In the memecoin space there is not yet a rabbit token that has succeeded, and our goal is to change that through memes, community building and accesibility to $BUX.

Bux The Rabbit

The community is rallying behind BUX due to the team's commitment to long-term development, including recent gaming partnerships and a focus on building a sustainable project ecosystem. Investors are highlighting the project's transparency and ongoing expansion efforts as key drivers for their bullish outlook.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight analysts that are covering the stock, Marketbeat Ratings reports...

Enanta Pharmaceuticals (NASDAQ:ENTA) Shares Pass Below 200 Day Moving Average - Should You Sell?

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Crosses Below Two Hundred Day Moving Average - Here's Why...

Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that...

Enanta Pharmaceuticals (NASDAQ:ENTA) Now Covered by Analysts at Rodman & Renshaw

Rodman & Renshaw started coverage on Enanta Pharmaceuticals in a research note on Thursday. They issued a "buy" rating and a $20.00 target price for the company...

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Crosses Below Two Hundred Day Moving Average   - What's Next?

Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Passes Below 200 Day Moving Average - Time to Sell...

Enanta Pharmaceuticals Pitches RSV Phase 3 Plans, Expands Oral Immunology Pipeline at Citizens Conference

Enanta Pharmaceuticals (NASDAQ:ENTA) used a presentation at the Citizens Life Sciences Conference to outline its evolving pipeline strategy, highlighting late-stage ambitions in respiratory syncytial...

Commodore Capital LP Buys New Holdings in Enanta Pharmaceuticals, Inc. $ENTA

Commodore Capital LP purchased a new position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund...

Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference

What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock

Enanta Pharmaceuticals (ENTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.51	--	--	N/A
Q1 '26	-$0.77	-$0.42	45.29%	BEAT
Q4 '25	-$1.03	-$0.87	15.26%	BEAT
Q3 '25	-$0.90	-$0.85	5.56%	BEAT
Q2 '25	-$1.15	-$1.06	7.56%	BEAT

ENTA
Enanta Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ENTA News

ENTAEnanta Pharmaceuticals Inc